Rheumatoid Arthritis Drugs Market Size, Share, And Growth Report 2032

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global rheumatoid arthritis drugs market, 2016-2025 (USD Billion)
  • 2.2. Global rheumatoid arthritis drugs market: snapshot
•  
• Chapter 3. Rheumatoid Arthritis Drugs Market - Industry Dynamics
  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Global rheumatoid arthritis drugs market drivers: impact analysis
    • 3.2.2. The increasing acceptance of large molecules biologics and biosimilars by rheumatologists
    • 3.2.3. Well-defined reimbursement and regulatory framework in developed regions
    • 3.2.4. Improving treatment options for moderate-to-severe rheumatoid arthritis with second-line therapies
    • 3.2.5. Reorientation of treatment approach from the relief of symptoms to targeted therapy to achieve disease remission
  • 3.3. Market Restraints
    • 3.3.1. Global rheumatoid arthritis drugs market restraints: impact analysis
    • 3.3.2. Treatment accessibility
    • 3.3.3. Patent expiration of blockbuster drugs
    • 3.3.4. Alternative treatment options for rheumatoid arthritis
  • 3.4. Opportunities
    • 3.4.1. Growth opportunities for companies operating in the market
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis, by drug type
    • 3.6.2. Market attractiveness analysis, by distribution channel
    • 3.6.3. Market attractiveness analysis, by region
•  
• Chapter 4. Global Rheumatoid Arthritis Drugs Market - Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global rheumatoid arthritis drugs market: company market share, 2018
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New therapy launch
    • 4.2.3. Agreements, partnerships, collaborations and joint ventures
    • 4.2.4. Research and development and regional expansion
  • 4.3. Price trend analysis
•  
• Chapter 5. Global Rheumatoid Arthritis Drugs Market - Drug Type Analysis
  • 5.1. Global rheumatoid arthritis drugs market: drug type overview
    • 5.1.1. Global rheumatoid arthritis drugs market revenue share, by drug type, 2018 and 2025
  • 5.2. NSAID's
    • 5.2.1. Global rheumatoid arthritis drugs market for NSAID's, 2016-2025 (USD Billion)
  • 5.3. Analgesics
    • 5.3.1. Global rheumatoid arthritis drugs market for analgesics, 2016-2025 (USD Billion)
  • 5.4. DMARD's
    • 5.4.1. Global rheumatoid arthritis drugs market for DMARD's, 2016-2025 (USD Billion)
  • 5.5. Glucocorticoids
    • 5.5.1. Global rheumatoid arthritis drugs market for glucocorticoids, 2016-2025 (USD Billion)
  • 5.6. Biologics
    • 5.6.1. Global rheumatoid arthritis drugs market for biologics, 2016-2025 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global rheumatoid arthritis drugs market for others, 2016-2025 (USD Billion)
•  
• Chapter 6. Global Rheumatoid Arthritis Drugs Market - Distribution Channel Analysis
  • 6.1. Global rheumatoid arthritis drugs market: distribution channel overview
    • 6.1.1. Global rheumatoid arthritis drugs market revenue share, by distribution channel, 2018 and 2025
  • 6.2. Hospital Pharmacies
    • 6.2.1. Global rheumatoid arthritis drugs market for hospital pharmacies, 2016-2025 (USD Billion)
  • 6.3. Retail Pharmacies
    • 6.3.1. Global rheumatoid arthritis drugs market for retail pharmacies, 2016-2025 (USD Billion)
  • 6.4. Drug Stores
    • 6.4.1. Global rheumatoid arthritis drugs market for drug stores, 2016-2025 (USD Billion)
  • 6.5. Online Sales
    • 6.5.1. Global rheumatoid arthritis drugs market for online sales, 2016-2025 (USD Billion)
•  
• Chapter 7. Global Rheumatoid Arthritis Drugs Market - Regional Analysis
  • 7.1. Global rheumatoid arthritis drugs market: regional overview
    • 7.1.1. Global rheumatoid arthritis drugs market revenue share, by region, 2018 and 2025
  • 7.2. North America
    • 7.2.1. North America rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
    • 7.2.2. North America rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 7.2.3. The U.S.
      • 7.2.3.1. The U.S. rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
      • 7.2.3.2. The U.S. rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 7.2.4. Canada
      • 7.2.4.1. Canada rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
      • 7.2.4.2. Canada rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
  • 7.3. Europe
    • 7.3.1. Europe rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
    • 7.3.2. Europe rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 7.3.3. U.K.
      • 7.3.3.1. U.K. rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
      • 7.3.3.2. U.K. rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 7.3.4. Germany
      • 7.3.4.1. Germany rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
      • 7.3.4.2. Germany rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 7.3.5. France
      • 7.3.5.1. France rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
      • 7.3.5.2. France rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 7.3.6. Rest of Europe
      • 7.3.6.1. Rest of Europe rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
      • 7.3.6.2. Rest of Europe rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
    • 7.4.2. Asia Pacific rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 7.4.3. China
      • 7.4.3.1. China rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
      • 7.4.3.2. China rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 7.4.4. Japan
      • 7.4.4.1. Japan rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
      • 7.4.4.2. Japan rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 7.4.5. India
      • 7.4.5.1. India rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
      • 7.4.5.2. India rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 7.4.6. Rest of Asia Pacific
      • 7.4.6.1. Rest of Asia Pacific rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
      • 7.4.6.2. Rest of Asia Pacific rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
  • 7.5. Latin America
    • 7.5.1. Latin America rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
    • 7.5.2. Latin America rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 7.5.3. Brazil
      • 7.5.3.1. Brazil rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
      • 7.5.3.2. Brazil rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 7.5.4. Rest of Latin America
      • 7.5.4.1. Rest of Latin America rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
      • 7.5.4.2. Rest of Latin America rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
  • 7.6. The Middle East and Africa
    • 7.6.1. The Middle East and Africa rheumatoid arthritis drugs market revenue, by drug type, 2016-2025 (USD Billion)
    • 7.6.2. The Middle East and Africa rheumatoid arthritis drugs market revenue, by distribution channel, 2016-2025 (USD Billion)
•  
• Chapter 8. Company Profiles
  • 8.1. Boehringer Ingelheim GmbH
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product portfolio
    • 8.1.4. Business strategy
    • 8.1.5. Recent developments
  • 8.2. Regeneron Pharmaceuticals, Inc.
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product portfolio
    • 8.2.4. Business strategy
    • 8.2.5. Recent developments
  • 8.3. Johnson & Johnson
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product portfolio
    • 8.3.4. Business strategy
    • 8.3.5. Recent developments
  • 8.4. Amgen, Inc.
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product portfolio
    • 8.4.4. Business strategy
    • 8.4.5. Recent developments
  • 8.5. UCB S.A.
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product portfolio
    • 8.5.4. Business strategy
    • 8.5.5. Recent developments
  • 8.6. Pfizer, Inc.
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product portfolio
    • 8.6.4. Business strategy
    • 8.6.5. Recent developments
  • 8.7. Bristol-Myers Squibb
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Product portfolio
    • 8.7.4. Business strategy
    • 8.7.5. Recent developments
  • 8.8. AbbVie
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Product portfolio
    • 8.8.4. Business strategy
    • 8.8.5. Recent developments
  • 8.9. F. Hoffmann-La Roche AG
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Product portfolio
    • 8.9.4. Business strategy
    • 8.9.5. Recent developments
  • 8.10. Novartis International AG
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Product portfolio
    • 8.10.4. Business strategy
    • 8.10.5. Recent developments

Table Of Figures

List of Figures 

1. Market research process
2. Market methodology
3. Global rheumatoid arthritis drugs market revenue, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Rheumatoid Arthritis Drugs market attractiveness analysis, by drug type
6. Rheumatoid Arthritis Drugs market attractiveness analysis, by distribution channel
7. Rheumatoid Arthritis Drugs market attractiveness analysis, by region
8. Company market share analysis, 2018
9. Global rheumatoid arthritis drugs market revenue share by drug type, 2018 and 2025
10. Global rheumatoid arthritis drugs market for NSAID’s, 2016–2025 (USD Billion)
11. Global rheumatoid arthritis drugs market for analgesics, 2016–2025 (USD Billion)
12. Global rheumatoid arthritis drugs market for DMARD’s, 2016–2025 (USD Billion)
13. Global rheumatoid arthritis drugs market for glucocorticoids, 2016–2025 (USD Billion)
14. Global rheumatoid arthritis drugs market for biologics, 2016–2025 (USD Billion)
15. Global rheumatoid arthritis drugs market for others, 2016–2025 (USD Billion)
16. Global rheumatoid arthritis drugs market revenue share by distribution channel, 2018 and 2025
17. Global rheumatoid arthritis drugs market for hospital pharmacies, 2016–2025 (USD Billion)
18. Global rheumatoid arthritis drugs market for retail pharmacies, 2016–2025 (USD Billion)
19. Global rheumatoid arthritis drugs market for drug stores, 2016–2025 (USD Billion)
20. Global rheumatoid arthritis drugs market for online sales, 2016–2025 (USD Billion)
21. North America rheumatoid arthritis drugs market,2016–2025 (USD Billion)
22. Europe rheumatoid arthritis drugs market,2016–2025 (USD Billion)
23. Asia Pacific rheumatoid arthritis drugs market,2016–2025 (USD Billion)
24. Latin America rheumatoid arthritis drugs market,2016–2025 (USD Billion)
25. The Middle East and Africa rheumatoid arthritis drugs market,2016–2025 (USD Billion)

Table Of Tables

List of Tables

1. Rheumatoid Arthritis Drugs market: market snapshot                                                                                                                  
2. Drivers of global rheumatoid arthritis drugs market: impact analysis 
3. Restraints of global rheumatoid arthritis drugs market: impact analysis  
4. North America rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
5. North America rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
6. The U.S. rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
7. The U.S. rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
8. Canada rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
9. Canada rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
10. Europe rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
11. Europe rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
12. U.K. rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
13. U.K. rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
14. Germany rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
15. Germany rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
16. France rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
17. France rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
18. Rest of Europe rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
19. Rest of Europe rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
20. Asia Pacific rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
21. Asia Pacific rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
22. China rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
23. China rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
24. Japan rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
25. Japan rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
26. India rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
27. India rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
28. Rest of Asia Pacific rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
29. Rest of Asia Pacific rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
30. Latin America rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
31. Latin America rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
32. Brazil rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
33. Brazil rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
34. Rest of Latin America rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
35. Rest of Latin America rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)
36. The Middle East and Africa rheumatoid arthritis drugs market revenue, by drug type, 2016–2025 (USD Billion)
37. The Middle East and Africa rheumatoid arthritis drugs market revenue, by distribution channel, 2016–2025 (USD Billion)